Skip to main
PHR
PHR logo

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 43%
Buy 57%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia Inc. demonstrates a positive financial outlook as indicated by its total revenue growth of 15.4% year-over-year, primarily driven by a substantial 28.5% increase in revenue from Network Solutions. The company reported strong pro forma operating margins of 14.9%, a significant improvement from a negative margin of 3.6% in the previous year, underscoring its operational efficiency. Furthermore, with an expected growth in the number of Accountable Healthcare Service Clients (AHSCs) to 4.5k and an anticipated increase in total revenue per AHSC, Phreesia is well-positioned to capitalize on emerging revenue opportunities.

Bears say

Phreesia Inc. exhibits concerning financial metrics and operational challenges that contribute to a negative outlook on its stock. Key indicators include stagnant payment-facilitator volume at 82% year-over-year, alongside a sequential decline in take rate from 2.82% to 2.79%, signaling potential difficulties in revenue generation. Additionally, the company's postponement of its $500 million run-rate revenue target from FY25 to FY26 reflects a cautious stance in response to current capital market conditions and economic uncertainties, suggesting potential growth vulnerabilities ahead.

Phreesia Inc (PHR) has been analyzed by 21 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 57% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 21 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $35.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $35.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.